310 related articles for article (PubMed ID: 22363553)
1. Physician and patient predictors of evidence-based prescribing in heart failure: a multilevel study.
Peters-Klimm F; Laux G; Campbell S; Müller-Tasch T; Lossnitzer N; Schultz JH; Remppis A; Jünger J; Nikendei C
PLoS One; 2012; 7(2):e31082. PubMed ID: 22363553
[TBL] [Abstract][Full Text] [Related]
2. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
3. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
[TBL] [Abstract][Full Text] [Related]
4. Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy.
Peters-Klimm F; Müller-Tasch T; Schellberg D; Remppis A; Barth A; Holzapfel N; Jünger J; Herzog W; Szecsenyi J
Clin Res Cardiol; 2008 Apr; 97(4):244-52. PubMed ID: 18046524
[TBL] [Abstract][Full Text] [Related]
5. Self-reported and actual beta-blocker prescribing for heart failure patients: physician predictors.
Sinha S; Schwartz MD; Qin A; Ross JS
PLoS One; 2009 Dec; 4(12):e8522. PubMed ID: 20046824
[TBL] [Abstract][Full Text] [Related]
6. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
[TBL] [Abstract][Full Text] [Related]
7. Reasons for not prescribing guideline-recommended medications to adults with heart failure.
Steinman MA; Dimaano L; Peterson CA; Heidenreich PA; Knight SJ; Fung KZ; Kaboli PJ
Med Care; 2013 Oct; 51(10):901-7. PubMed ID: 23969589
[TBL] [Abstract][Full Text] [Related]
8. Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart Failure Adherence Retention Trial (HART).
Calvin JE; Shanbhag S; Avery E; Kane J; Richardson D; Powell L
Congest Heart Fail; 2012; 18(2):73-8. PubMed ID: 22432552
[TBL] [Abstract][Full Text] [Related]
9. Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.
Kruik-Kollöffel WJ; Linssen GCM; Kruik HJ; Movig KLL; Heintjes EM; van der Palen J
Heart Fail Rev; 2019 Jul; 24(4):499-510. PubMed ID: 30848404
[TBL] [Abstract][Full Text] [Related]
10. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
Hirt MN; Muttardi A; Helms TM; van den Bussche H; Eschenhagen T
Clin Res Cardiol; 2016 May; 105(5):441-50. PubMed ID: 26552905
[TBL] [Abstract][Full Text] [Related]
11. Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF.
Tebbe U; Tschöpe C; Wirtz JH; Lokies J; Turgonyi E; Bramlage P; Strunz AM; Lins K; Böhm M
Clin Res Cardiol; 2014 Aug; 103(8):665-73. PubMed ID: 24535376
[TBL] [Abstract][Full Text] [Related]
12. Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study.
Mahmoudpour SH; Asselbergs FW; Souverein PC; de Boer A; Maitland-van der Zee AH
Br J Clin Pharmacol; 2018 Oct; 84(10):2365-2372. PubMed ID: 29943849
[TBL] [Abstract][Full Text] [Related]
13. Prescription and dosage of RAAS inhibitors in patients with chronic heart failure in the FAR NHL registry.
Špinarová M; Špinar J; Pařenica J; Špinarová L; Málek F; Lábr K; Ludka O; Jarkovský J
Vnitr Lek; 2019; 65(1):13-14. PubMed ID: 30823832
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors in heart failure: physicians' prescribing behavior.
Ferreira A; Bettencourt P; Cortez M; Araújo JP; Cerqueira-Gomes M
J Card Fail; 1997 Dec; 3(4):295-302. PubMed ID: 9547444
[TBL] [Abstract][Full Text] [Related]
15. Treatment of heart failure in real-world clinical practice: findings from the REFLECT-HF registry in patients with NYHA class II symptoms and a reduced ejection fraction.
Böhm M; Tschöpe C; Wirtz JH; Lokies J; Turgonyi E; Bramlage P; Lins K; Strunz AM; Tebbe U
Clin Cardiol; 2015 Apr; 38(4):200-7. PubMed ID: 25733185
[TBL] [Abstract][Full Text] [Related]
16. Prescribing Data in General Practice Demonstration (PDGPD) project--a cluster randomised controlled trial of a quality improvement intervention to achieve better prescribing for chronic heart failure and hypertension.
Williamson M; Cardona-Morrell M; Elliott JD; Reeve JF; Stocks NP; Emery J; Mackson JM; Gunn JM
BMC Health Serv Res; 2012 Aug; 12():273. PubMed ID: 22913571
[TBL] [Abstract][Full Text] [Related]
17. Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality.
Beusekamp JC; Tromp J; Cleland JGF; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Ouwerkerk W; van Veldhuisen DJ; Voors AA; van der Meer P
JACC Heart Fail; 2019 Nov; 7(11):970-979. PubMed ID: 31606364
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
[TBL] [Abstract][Full Text] [Related]
19. Use and risk management of carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring study.
Aurich-Barrera B; Wilton LV; Shakir SA
Drug Saf; 2009; 32(1):43-54. PubMed ID: 19132804
[TBL] [Abstract][Full Text] [Related]
20. Trends in co-prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in Ireland.
Wan Md Adnan WA; Zaharan NL; Bennett K; Wall CA
Br J Clin Pharmacol; 2011 Mar; 71(3):458-66. PubMed ID: 21284706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
